Basic Information

Gene symbol S Synonyms E2 Type of gene protein-coding
Gene perturbation-related omics dataset PerturbAtlas
Description spike glycoprotein

GTO ID GTC2946
Trial ID NCT05260437
Disease COVID-19
Altered gene S
Therapeutic/Target gene Therapeutic gene
TherapymRNA vaccine
Treatment CV2CoV mRNA Vaccine
PhasePhase1
Recruitment statusCompleted
TitleA Phase 1, Open-label, Safety, Reactogenicity, and Immunogenicity Trial of the CV2CoV mRNA Vaccine Against SARS CoV 2 in Seropositive Adult Participants
Year2022
CountryUnited States
Company sponsorGlaxoSmithKline
Other ID(s)217741

Clinical Result

Cohort1: CV2CoV_dose level 1
Administration route intramuscular injection
Dosage CV2CoV, 2 µg
Age Adult, Older_Adult
Cohort2: CV2CoV_dose level 2
Administration route intramuscular injection
Dosage CV2CoV, 4 µg
Age Adult, Older_Adult
Cohort3: CV2CoV_dose level 3
Administration route intramuscular injection
Dosage CV2CoV, 8 µg
Age Adult, Older_Adult
Cohort4: CV2CoV_dose level 4
Administration route intramuscular injection
Dosage CV2CoV, 12 µg
Age Adult, Older_Adult
Cohort5: CV2CoV_dose level 5
Administration route intramuscular injection
Dosage CV2CoV, 16 µg
Age Adult, Older_Adult
Cohort6: CV2CoV_dose level 6
Administration route intramuscular injection
Dosage CV2CoV, 20 µg
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph